Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127045731 | 12704573 | 1 | I | 20160502 | 20160831 | 20160831 | PER | US-SA-2016SA088075 | AVENTIS | 0.00 | E | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127045731 | 12704573 | 1 | PS | AVAPRO | IRBESARTAN | 1 | Unknown | Y | UNK | 20757 | QD | ||||||||
| 127045731 | 12704573 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127045731 | 12704573 | Aneurysm | |
| 127045731 | 12704573 | Arthralgia | |
| 127045731 | 12704573 | Burning sensation | |
| 127045731 | 12704573 | Fall | |
| 127045731 | 12704573 | Gastric disorder | |
| 127045731 | 12704573 | Hypertension | |
| 127045731 | 12704573 | Insomnia | |
| 127045731 | 12704573 | Nail growth abnormal | |
| 127045731 | 12704573 | Pruritus generalised | |
| 127045731 | 12704573 | Rash | |
| 127045731 | 12704573 | Skin mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127045731 | 12704573 | 1 | 2014 | 0 |